Clinical eVects and safety of topically applied RXM
on hair restoration in Androgenetic Alopecia
A total of 24 patients were enrolled in the study. Baseline
characteristics of enrolled patients were not signiWcantly
diVerent between the two treatment groups and are summa-
rized in Table1.
Global photographic assessment
At 24weeks, 7 out of 13 patients (58%) in RXM group
demonstrated improvement relative to baseline in global
photographic assessment. In detail, the patients with greatly
improved, improved and slightly improved hair restoration
were 7, 34 and 17%, respectively (Fig. 4a). The rest (42%)
did not show the restoration eVect (no change or
progression of hair loss). On the other hand, none showed
improvement in the control group (n=11). Vertex global
photographic assessment scores at 24weeks were 2.08
§
1.03 and 0.09 for RXM-treated and control patients, respec-
tively (P<0.01). Representative global photographs of
patients rated as having increased hair growth (RXM) or
deterioration (placebo) at 24weeks are shown in Fig. 4b.
Assessment of hair shaft thickness
The hair shaft thickness was signiWcantly increased after
24weeks (86.8